This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Sarah Cannon Research Institute
scri.com
did:plc:cgpwq6jbgzg5zb3sshw24l57
Meredith Pelster, MD, SCRI Oncology Partners serves as a contributing author on a @nejm.org publication on daraxonrasib in previously treated RAS‑mutated pancreatic cancer. Important progress for pancreatic cancer research. Article: https://nejm.org/doi/10.1056/NEJMoa2505783?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
#NEJM #PancreaticCancer
2026-05-12T17:44:33.364Z